Patent · US Active

Methods for treating Parkinson's disease

US9387212B2 · kind B2 · utility

7Cited by

0References

12Claims

0Family size

Assignee

UCB BIOPHARMA SRL · BE

Inventors

Anne Michel · Carlsbad, US
Patrick Downey · Brussels, BE
Florian Montel · Meitingen, DE
Dieter Scheller · Brussels, BE
Bernard Christophe · Brussels, BE

Key dates

Filing date	Apr 19, 2013
Grant date	Jul 12, 2016
Priority date	—
Expiry date	Apr 19, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A2A) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.